Off-Label Use of Atypical Antipsychotics: An Update
Introduction to Atypical Antipsychotics (3 of 4)
Several atypical antipsychotics are approved for indications in addition to primary psychoses, including autism spectrum disorders, bipolar depression, and major depressive disorder. Prescribing of atypical antipsychotics has expanded beyond these approved indications.
Keywords: aripiprazole | atypical antipsychotics | autism | autism spectrum disorders | bipolar | major depressive disorder | MDD | off-label | olanzapine | quetiapine | risperidone | second generation | antipsychotics
- Maglione M, Ruelaz Maher A, Hu J, et al. Off-Label Use of Atypical Antipsychotics: An Update. Comparative Effectiveness Review No. 43 (Prepared by the Southern California RAND Evidence-based Practice Center under Contract No. HHSA 290-2007-10062-I). Rockville, MD: Agency for Healthcare Research and Quality; September 2011. AHRQ Publication No. 11(12)-EHC087-EF. Available at www.effectivehealthcare.ahrq.gov/offlabelantipsych.cfm.
Your slide tray is being processed.